NuGen Medical Devices Inc (TSE:NGMD) has released an update.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
NuGen Medical Devices Inc. has released its Q1 2024 financial results, which align with management’s expectations and reflect strides in smaller markets ahead of a Q2 ramp-up with new distribution partners in major markets. The company has strengthened its financial position by renegotiating long-term debt, and under new leadership, is focusing on commercializing its needle-free InsuJet device, with increased efforts in patient awareness, distribution execution, and clinical community education.
For further insights into TSE:NGMD stock, check out TipRanks’ Stock Analysis page.